Ova otkrića su iz 13D podnesenih Komisiji za hartije od vrijednosti. 13D se podnose u roku od 10 dana od trenutka kada entitet dostigne više od 5% u bilo kojoj klasi hartija od vrijednosti kompanije. Naknadne promjene u posjedu ili namjerama moraju se prijaviti u izmijenjenim podnescima. Ovaj materijal je od 24. novembra do 30. novembra 2022. Izvor: VerityData
Original Filings
Acrivon Therapeutics
(ACRV)
RA Capital revealed a fresh stake of 4,813,442 shares in the clinical-stage pharmaceutical firm, including 2,934 shares underlying options. RA Capital purchased 3,389,500 shares at $12.50 each through Acrivon’s November initial public offering. RA Capital gained another 1,421,008 Acrivon shares through the conversion of pre-IPO convertible preferred securities immediately after the offering closed on Nov. 17. RA Capital now owns a 23.1% stake in Acrivon.
Source: https://www.barrons.com/articles/irobot-and-acrivon-stock-see-action-from-activist-investors-51670024193?siteid=yhoof2&yptr=yahoo